Tenaya Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tenaya Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $912.00K.
- Tenaya Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $3.87M.
- Tenaya Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $188.54M.
- Tenaya Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2025 was $912.00K.
- Tenaya Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2023 was $3.87M.
- Tenaya Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $188.54M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $912.00K 10-K · filed 2026-03-11 | |
| 2025-03-31 | $912.00K 10-Q · filed 2026-08-05 | |
| 2023-12-31 | $3.87M 10-K · filed 2025-03-10 | |
| 2023-06-30 | $3.87M 10-Q · filed 2024-11-06 | |
| 2021-12-31 | $188.54M 10-K · filed 2022-03-23 | |
| 2021-09-30 | $188.54M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |